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Background

Data

Understanding the Problem

Introduction

Root Cause Analysis

• Between 2013 and 2017, about 45,000 HPV-related
cancers were diagnosed in the US per year
• Of these, cervical cancer is the most common and is
almost exclusively caused by HPV
• About two-thirds of vulvar/vaginal and penile cancers
are the result of HPV infection
• Vaccination has potential to dramatically reduce
incidence of these cancers, and nearly eliminate
cervical cancer. Nationally, only 51% of teens are fully
vaccinated against HPV and Oregon averages 58-59%.

In order to understand the problem, we:
• Mapped clinic workflows and driver through a swim lane
diagram and a driver diagram.
• Interviewed the stakeholders (clinic managers, MA, faculty
physician)
We identified the following areas as opportunities for
intervention:
• Parent and child education regarding the vaccine-side effects
and cancer prevention rather than STD prevention
• Limited access to provider, creating alternative MA vaccine
• Patient reminder, especially during decrease WCC during
pandemic
• Clinic availability in setting of covid isolation

Background Research and Literature Review
Many interventions to improve HPV vaccination rates
have been undertaken and studied. Interventions we
found include:
• Boston FQHC demonstrated an increased likelihood of
vaccination by >10 percentage points and completion
rates by age 13 by 4 percentage points, when the HPV
vaccination was initiated at age 9-10
• Another large study (n=36,000) of one entire MN
county showed a strong association between vaccine
initiation at age 9-10 and series completion by age 1315 (when compared with initiation at age 11-12)
• Standing orders and patient reminders have improved
vaccine rates in multiple studies
Other takeaways:
• Peer-to-peer
provider
education
was
not
demonstrated to be effective
• Few interventions were aimed at addressing parental
resistance to vaccination
• Pharmacists are now licensed to administer pediatric
vaccines

Project Aim Statement
Increase completed HPV vaccination rates from 68%
to 80% in adolescents younger than 15 years old by April
1st, 2021 at the Providence Milwaukie Family Medicine
Clinic.
• Outcome Measure: Completion of vaccination series
by age 15 (end of 2 dose series)
• Process Measure: initiation and completion of on
time vaccination by age 13
• Balancing Measure: Tdap and MCV vaccination rate
by age 13
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Methods
PDSA 1 – Staff/Provider Education
• Plan/Do: Clinic wide intervention included a collaborative education
session/CME "You are the Key" with American Cancer Society, including
education on vaccine education, bundling and cancer prevention
messaging. Patient education material in HPV Cancer Free education
posters, exam and waiting room screen savers.
• Study/Act: We recorded pre and post intervention vaccination rates via
EPIC healthy planet system. Results were complicated by COVID related
decline in all vaccination rates. Our clinic will continue provide poster
and screen saver information around our clinic.

PDSA 2 – Telephone Encounters
• Plan/Do: A clinic team level intervention to use vaccine registry to
identify and contact patients who initiated, but did not complete the
vaccine series. Improve access through standard WCC, virtual WCC with
MA vaccine only visit, or just MA vaccine visit only.
• Study/Act: This method was tested on a single team within the clinic
with a patient scheduling rate of 33%. However, this intervention was
found to be labor intensive to multiple clinical staff and difficult to
complete on top of current workload. This method was not expanded
to the clinic wide these barriers. MA vaccine visits proved good access.

PDSA 3 – Partnering with Population Health
• Plan/Do: Using vaccine registry, patients age 11-12 due for HPV
vaccine received targeted outreach via a text message to parents and
link to new mobile platform for scheduling, followed up with a 30-day
letter for non-responders. Patients age 13-15 due for HPV that receive a
Warm Call.
• Study/Act: 164 total patients were identified for outreach. 43 patients
scheduled or had appts completed resulting in a positive scheduling
rate of 26.2% overall. There was a slightly higher response rate from
the age 13-15 group, 30.5% vs 23.8%. This outreach has been instituted
and population health will continue these outreach interventions

Conclusions / Lessons Learned
• The COVID-19 pandemic, stay at home orders and significant decline in adolscent well
child care significantly complicated QI
• A decline in vaccination rates was seen across all childhood vaccinations during this
year. The CDC reported 3 million fewer non-influenza vaccination orders in April 2020
compared to April 2019.
• Commonwealth Fund study demonstrated a 71% decrease in office visits for school
age children.

• Population Health outreach demonstrated fair response rates. There may be a higher
response rate to warm call methods vs text/mobile platform, however the sample size
was small (59 patients in warm call group) and the technology is promising.
• Moving forward we plan to continue patient and provider education HPV vaccination
and cancer prevention. Continue providing access through virtual WCC and MA
vaccine only visit.
• Population Health is a powerful partner in reaching patients with innovative and
persistent approaches.

• Future interventions that hold promise include:
• Standing orders, though system barriers persist to this we were not able to overcome.

• Adopted system provider reminders and [patient education for vaccine initiation at 910 years old.
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